Post Profile






Big data analysis is 'next frontier' in identifying harmful drug interactions

(American College of Cardiology) Coupling data mining of adverse event reports and electronic health records with targeted laboratory experiments, researchers found a way to identify and confirm previously unknown drug interactions, according to a study published today in the Journal of the American College of Cardiology.
read more

share

Related Posts


Harmful Alcohol Use Increases Health Risks in All Countries

Health : Newswise Medical News

Data support the call to increase global awareness of the harmful use of alcohol and the need to further identify and target the modifiable determinants of harmful alcohol use. The authors also identified differences between countri...

Scientists identify 20 potential drug target genes involved in the process of remembering negative events

Health : Medical News Today

Through analysis of the human genome, Basle scientists have identified molecules and compounds that are related to human memory. In a subsequent pharmacological study with one of the identified compounds, the scientists found a drug...

Safer drug combinations possible using available data

Health : Medical News Today

Using the Food and Drug Administration's Adverse Event Reporting System (FAERS), a hospital electronic health records database, and an animal model, a team of researchers at the Icahn School of Medicine at Mount Sinai report that by...

Big Data Reaps Big Rewards in Drug Safety

Health : Newswise Medical News

Using the Food and Drug Administration's Adverse Event Reporting System (FAERS), a hospital electronic health records database, and an animal model, a team of researchers at the Icahn School of Medicine at Mount Sinai report that by...

Researchers Identify Novel Mechanism in Combination Drug Therapy for Acute Myeloid Leukemia, Other Cancers

Health : Newswise Medical News

Researchers have discovered a novel mechanism in a combination drug therapy that shows potential as a new approach for treating acute myeloid leukemia (AML) and many other cancers. When combined, these agents cause interactions that...

Comments


Copyright © 2016 Regator, LLC